EQT Corporation (NYSE:EQT) Gains on Earnings: EQT, IDIX, PINK:MJNA, PINK:HEMP, ONVO

Lakeway, NY -- (SBWIRE) -- 02/06/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

EQT Corporation (NYSE:EQT) shares jumped 3.39% and closed at $61.88 in the last trading session. The company, on Jan. 24, announced fourth quarter 2012 financial and operating results. Net income for the quarter totaled $20.2 million and adjusted EBITDA was $22.8 million. Distributable cash flow was $14.8 million for the quarter. Adjusted operating income when compared to the same quarter last year was higher by about $2.3 million, or 14%, excluding a $2.5 million non-cash favorable adjustment to fourth quarter selling, general and administrative expense related to the reduction of a reserve on the collectability of long-term regulatory assets.

Looking forward, the company announced that for fiscal 2013, it expects production sales volumes to be between 335 and 340 Bcfe, 31% higher than in 2012.

Is EQT a Buy After The Consolidation Following a Sharp Jump After Earnings?

Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) shares gained 3.38% to $4.89. The company, on Jan. 28, announced a non-exclusive collaboration with Janssen Pharmaceuticals, Inc. for the clinical development of all-oral direct-acting antiviral (DAA) HCV combination therapies. The collaboration will evaluate combinations including IDX719, Idenix's once-daily pan-genotypic NS5A inhibitor, simeprevir (TMC435), a once-daily protease inhibitor jointly developed by Janssen and Medivir AB, and TMC647055, a once-daily non-nucleoside polymerase inhibitor, boosted with low dose ritonavir, being developed by Janssen.

What Should Be The Fair Value Of IDIX After The Slump? Let’s Find Out Here

Medical Marijuana Inc. (PINK:MJNA) slipped 28.27% and closed at $0.307 on a traded volume of 66.62 million shares. Earlier, the Company pre-announces its fourth quarter earnings. The net income was $3.39 million in the fourth quarter. The gross revenues were $5.10 million, an increase of $4.5 million and over 1,100% from the previous year quarter. The Company provided an update on the expansion of its Red Dice Holdings Dixie Elixirs & Edibles brand nationally and in Colorado through additional market penetration and product development.

Is MJNA a Buy Or Sell After The Solid Momentum? Find Out Here

HEMP, INC. (PINK:HEMP) augmented 23.46% and closed at $0.10 on a traded volume of 66.19 million shares. Recently, the Company officially launched its second spinoff, YourBev Structured Water and Functional Beverage Company, Inc. Hemp, Inc. focuses on the vast market created by the quickly emerging, and growing, multibillion dollar industrial hemp industry. Hemp, Inc. is not involved in the cultivation or marketing of medical marijuana.

Get Live Earnings Report On U.S. Stock Here

Organovo Holdings Inc. (PINK:ONVO) soared 7.91% and closed at $4.50 on a traded volume of 898k shares. The company plans to redeem two classes of outstanding warrants initially issued to investors participating in private placement financings in 2011 and 2012. The warrant redemption will raise non-dilutive capital, enable Organovo to significantly improve its balance sheet, help position the Company to qualify to list its common stock on the NYSE MKT or NASDAQ exchange and decrease a significant portion of the derivative liability from its balance sheet.

How Should Investors Trade ONVO Now? Find Out Here

About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at www.ThePennyStockProfiler.com

Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.